title: The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes.
authors.forename: Lisette
authors.initials: L
authors.lastname: Salvesen
authors.forename: Sara
authors.initials: S
authors.lastname: Bech
authors.forename: Annemette
authors.initials: A
authors.lastname: Lokkegaard
authors.forename: Lena E
authors.initials: LE
authors.lastname: Hjermind
authors.forename: Jørgen E
authors.initials: JE
authors.lastname: Nielsen
authors.forename: Bente
authors.initials: B
authors.lastname: Pakkenberg
authors.forename: Julia T
authors.initials: JT
authors.lastname: Tanassi
authors.forename: Niels H H
authors.initials: NH
authors.lastname: Heegaard
authors.forename: Kristian
authors.initials: K
authors.lastname: Winge
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000134:cerebrospinal fluid* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D015513:Oncogene Proteins / Q000134:cerebrospinal fluid* / Q000378:metabolism; D020734:Parkinsonian Disorders / Q000134:cerebrospinal fluid* / Q000175:diagnosis; D000071617:Protein Deglycase DJ-1
chemical_list: D015415:Biomarkers; D047908:Intracellular Signaling Peptides and Proteins; D015513:Oncogene Proteins; C105131:PARK7 protein, human; D000071617:Protein Deglycase DJ-1